دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Population ageing in China: crisis or opportunity?
doi : 10.1016/S0140-6736(22)02410-2
Volume 400, Issue 10366, 26 November–2 December 2022, Page 1821
Bivalirudin in patients with ST-segment elevation myocardial infarction
J J Coughlan, *Adnan Kastrati
doi : 10.1016/S0140-6736(22)02162-6
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1822-1823
A revolution in the management of multidrug-resistant tuberculosis
*Keertan Dheda, Christoph Lange
doi : 10.1016/S0140-6736(22)02161-4
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1823-1825
Gut–hormone triple agonists: clinical safety and metabolic benefits
*Timo D Müller, Matthias H Tschöp
doi : 10.1016/S0140-6736(22)02350-9
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1826-1828
New WHO recommendations for the care of preterm or low birthweight infants have the potential to transform maternal and newborn health-care delivery
doi : 10.1016/S0140-6736(22)02186-9
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1828-1831
The NIH Climate Change and Health Initiative and Strategic Framework: addressing the threat of climate change to health
*Richard P Woychik, Diana W Bianchi, Gary H Gibbons,Roger I Glass, Joshua A Gordon, Eliseo J Pérez-Stable,Shannon N Zenk
doi : 10.1016/S0140-6736(22)02163-8
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1831-1833
Offline: The distance between us
Richard Horton
doi : 10.1016/S0140-6736(22)02413-8
Volume 400, Issue 10366, 26 November–2 December 2022, Page 1834
COP27: a “collective failure�
Nayanah Siva
doi : 10.1016/S0140-6736(22)02407-2
Volume 400, Issue 10366, 26 November–2 December 2022, Page 1835
The UK and Italy make delayed Global Fund pledges
Sharmila Devi
doi : 10.1016/S0140-6736(22)02408-4
Volume 400, Issue 10366, 26 November–2 December 2022, Page 1836
HPV and diabetes researchers win Prince Mahidol Awards
Talha Burki
doi : 10.1016/S0140-6736(22)02409-6
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1837-1838
Rosa Ritunnano: champion of phenomenology in psychiatry
Sophia Davis
doi : 10.1016/S0140-6736(22)02364-9
Volume 400, Issue 10366, 26 November–2 December 2022, Page 1839
Forced to uphold white supremacy, until we couldn’t anymore
*Ananya Banerjee, Amy Tan
doi : 10.1016/S0140-6736(22)02366-2
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1840-1841
Dilip Mahalanabis
Andrew Green
doi : 10.1016/S0140-6736(22)02367-4
Volume 400, Issue 10366, 26 November–2 December 2022, Page 1842
Free Şebnem Korur Fincancı and end systematic silencing of health professionals
*Michele Heisler, James Lin,Jens Modvig, Chris Esdaile,Vincent Iacopino
doi : 10.1016/S0140-6736(22)02359-5
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1843-1844
On the politics and ethics of strike action by health professionals
*James Smith, Ryan Essex, Rita Issa
doi : 10.1016/S0140-6736(22)02308-X
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1844-1845
Pharmacological interventions for insomnia disorder in adults
*Matthew J Reid, Andrew S Huhn,Patrick H Finan
doi : 10.1016/S0140-6736(22)02031-1
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1845-1846
Pharmacological interventions for insomnia disorder in adults – Authors' reply
*Andrea Cipriani, Edoardo G Ostinelli,Philip J Cowen
doi : 10.1016/S0140-6736(22)02001-3
Volume 400, Issue 10366, 26 November–2 December 2022, Page 1846
Department of Error
doi : 10.1016/S0140-6736(22)02363-7
Volume 400, Issue 10366, 26 November–2 December 2022, Page 1846
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
Yi Li*, Zhenyang Liang*, Lei Qin, Mian Wang, Xianzhao Wang, Huanyi Zhang, Yin Liu, Yan Li, Zhisheng Jia, Limin Liu, Hongyan Zhang, Jun Luo,Songwu Dong, Jincheng Guo, Hengqing Zhu, Shengli Li, Haijun Zheng, Lijun Liu, Yanqing Wu, Yiming Zhong, Miaohan Qiu, Yaling Han,Gregg W Stone
doi : 10.1016/S0140-6736(22)01999-7
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1847-1857
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial
Ruth L Goodall, Sarah K Meredith, Andrew J Nunn, Adamu Bayissa, Anuj K Bhatnagar, Gay Bronson, Chen-Yuan Chiang, Francesca Conradie,Meera Gurumurthy, Bruce Kirenga, Nana Kiria, Daniel Meressa, Ronelle Moodliar, Gopalan Narendran, Nosipho Ngubane, Mohammed Rassool,Karen Sanders, Rajesh Solanki, S Bertel Squire, Gabriela Torrea, Bazarragchaa Tsogt, Elena Tudor, Armand Van Deun, I D Rusen, for the STREAMstudy collaborators*
doi : 10.1016/S0140-6736(22)02078-5
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1858-1868
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Shweta Urva*, Tamer Coskun*, Mei Teng Loh, Yu Du, Melissa K Thomas, Sirel Gurbuz, Axel Haupt, Charles T Benson, Martha Hernandez-Illas,David A D’Alessio, Zvonko Milicevic
doi : 10.1016/S0140-6736(22)02033-5
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1869-1881
Bacterial infection possibly causing autoimmunity: Tropheryma whipplei and membranous nephropathy
Thorsten Wiech, Linda Reinhard, Sonia Wulf, Alfio Edoardo Giuffrida, Elisa Longhitano, Rosario Caruso, Hermann-Josef Gröne, Rolf A K Stahl,Peter F Zipfel, Judith Kikhney, Annette Moter, Elion Hoxha*, Domenico Santoro*
doi : 10.1016/S0140-6736(22)02039-6
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1882-1883
The evolving landscape of pulmonary arterial hypertension clinical trials
Jason Weatherald, Athénaïs Boucly, Anthony Peters, David Montani, Krishna Prasad, Mitchell A Psotka, Faiez Zannad, Mardi Gomberg-Maitland,Vallerie McLaughlin, Gérald Simonneau, Marc Humbert, on behalf of the participants of The Evolving Landscape of Pulmonary ArterialHypertension and Redesigning Pulmonary Arterial Hypertension Clinical Trials Task Force of the 18thGlobal CardioVascular Clinical Trialists Forum*
doi : 10.1016/S0140-6736(22)01601-4
Volume 400, Issue 10366, 26 November–2 December 2022, Pages 1884-1898
